e-learning
resources
Virtual 2021
07.09.2021
What's new in respiratory problems in rare and systemic diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Role of Discharge VTE Assessment in Correct VTE Prophylaxis Prescription
H. Myat Noe (Aylesbury, United Kingdom), M. Chinedu (Aylesbury, United Kingdom), R. Raju (Aylesbury, United Kingdom)
Source:
Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Session:
What's new in respiratory problems in rare and systemic diseases
Session type:
E-poster
Number:
3309
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Myat Noe (Aylesbury, United Kingdom), M. Chinedu (Aylesbury, United Kingdom), R. Raju (Aylesbury, United Kingdom). Late Breaking Abstract - Role of Discharge VTE Assessment in Correct VTE Prophylaxis Prescription. 3309
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Late Breaking Abstract - SUPRAnav: A Clinical Trial Evaluating the Efficacy and Safety of a New Invention Device Designed for Continuous Supraglottic Aspiration in Mechanically Ventilated Patients.
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Intensive care and infection
Year: 2019
Late Breaking Abstract - Real-World Characteristics of Patients Receiving Dupilumab in Routine Clinical Practice in a Multinational, Non-Interventional Study (ProVENT)
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
Meta-analysis on the Effect of Current Smoking on the Risk of Developing Community Acquired Pneumonia
Source: International Congress 2018 – Systematic reviews on the health effects of emerging tobacco products and electronic nicotine delivery systems (ENDS)
Year: 2018
Admission Avoidance and Early Supported Discharge with Home Monitoring in COVID-19 Patients
Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care
Year: 2021
Late Breaking Abstract - Dynamic Early Warning Score versus National Early Warning Score-2 for predicting death or intensive care unit admission in respiratory patients
Source: Virtual Congress 2021 – E-health for COVID-19
Year: 2021
Late Breaking Abstract - Arterial Stiffness and Cardiovascular Risk in hospitalised COPD patients
Source: International Congress 2019 – Imaging of airway diseases
Year: 2019
Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Late Breaking Abstract - Does The High Use Of Oral Antiasthmatics Contribute To The Elevated Burden Of Asthma In India?
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019
Late Breaking Abstract - Clinical Efficacy and Safety of Macitentan Transitioned from Bosentan in Patients with Pulmonary Arterial Hypertension
Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Year: 2018
Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Lung Cancer
Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism
Year: 2019
Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity
Source: International Congress 2019 – Bronchiectasis
Year: 2019
Evaluation of EFL Incidence and Impacts of Novel NIV Home Therapy
Source: Virtual Congress 2020 – Non-invasive ventilation and nasal high flow: technical aspects and predictive scores
Year: 2020
Late Breaking Abstract - Abdominal Muscle Function During Spontaneous Breathing Trials to Predict Extubation Failure
Source: Virtual Congress 2020 – Novel findings regarding acute respiratory distress syndrome, extra corporeal membrane oxygenation and weaning from mechanical ventilation
Year: 2020
Late Breaking Abstract - Influence of Weather Conditions on the Onset of Primary Spontaneous Pneumothorax: Positive Association with Occurrence of “clusters”
Source: International Congress 2017 – Late-breaking studies in pulmonary diseases
Year: 2017
Late Breaking Abstract - Balloon Pulmonary Angioplasty for the Treatment of Non Operable Chronic Thromboembolic Pulmonary Hypertension – Initial experience of a Belgian Center
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018
Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021
Clinical Risk Stratification of Pulmonary Embolism to Support the Development of a Pulmonary Embolism Response Team (PERT) at a Tertiary Referral Hospital.
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020
Is there an Optimal Door-to-Treatment Time for Acute Pulmonary Embolism? A National Propensity Match Analysis
Source: Virtual Congress 2020 – From diagnosis to management of pulmonary embolism
Year: 2020
COPD - Impact on Mortality in Locals with and without Specific Medication
Source: Virtual Congress 2021 – Lung disease burden and management
Year: 2021
Late Breaking Abstract - Improving adherence to prescribing remdesivir in COVID-19
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept